Volume 4 Issue 2
Apr.  2013
Turn off MathJax
Article Contents

doi: 10.3969/j.issn.1674-9081.2013.02.023
  • Received Date: 2012-12-04
  • Publish Date: 2013-04-30
  • loading
  • [1] Coumans FA, Ligthart ST, Uhr JW, et al. Challenges in the enumeration and phenotyping of CTC[J]. Clin Cancer Res, 2012, 18:5711-5718. doi:  10.1158/1078-0432.CCR-12-1585
    [2] 张贺龙, 蒋蔚峰.外周血循环肿瘤细胞检测的研究进展[J].临床肿瘤学杂志, 2010, 15:944-947. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=lczlxzz201010018
    [3] Wicha MS, Hayes DF. Circulating tumor cells:not all detected cells are bad and not all bad cells are detected[J]. J Clin Oncol, 2012, 29:1508-1511. https://www.ncbi.nlm.nih.gov/pubmed/21422428
    [4] Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer[J]. J Clin Oncol, 2007, 25:5287-5312. doi:  10.1200/JCO.2007.14.2364
    [5] Andreopoulou E, Yang LY, Rangel KM, et al. Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer:AdnaGen AdnaTest Breast Cancer Select/DetectTM versus Veridex CellSearchTM system[J]. Int J Cancer, 2012, 130:1590-1597. doi:  10.1002/ijc.26111
    [6] Mayer JA, Pham T, Wong KL, et al. FISH-based determination of HER2 status in circulating tumor cells isolated with the microfluidic CEETM platform[J]. Cancer Genet, 2011, 204:589-595. doi:  10.1016/j.cancergen.2011.10.011
    [7] Pecot CV, Bischoff FZ, Mayer JA, et al. A novel platform for detection of CK + and CK-CTCs[J]. Cancer Discov, 2011, 1:580-586. doi:  10.1158/2159-8290.CD-11-0215
    [8] Wu C, Hao H, Li L, et al. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients[J]. J Thorac Oncol, 2009, 4:30-36. doi:  10.1097/JTO.0b013e3181914125
    [9] Ellis WJ, Pfitzenmaier J, Colli J, et al. Detection and isolation of prostate cancer cells from peripheral blood and bone marrow[J]. Urology, 2003, 61:277-281. doi:  10.1016/S0090-4295(02)02291-4
    [10] Kønigsberg R, Obermayr E, Bises G, et al. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients[J]. Acta Oncol, 2011, 50:700-710. doi:  10.3109/0284186X.2010.549151
    [11] Khoja L, Backen A, Sloane R, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker[J]. Br J Cancer, 2012, 106:508-516. doi:  10.1038/bjc.2011.545
    [12] Farace F, Massard C, Vimond N, et al. A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas[J]. Br J Cancer, 2011, 105:847-853. doi:  10.1038/bjc.2011.294
    [13] Cho EH, Wendel M, Luttgen M, et al. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors[J]. Phys Biol, 2012, 9: 016001[2012-12-04]. http://iopscience.iop.org/1478-3975/9/1/016001/.
    [14] de Albuquerque A, Kubisch I, Breier G, et al. Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients:a feasibility study[J]. Oncology, 2012, 82:3-10. doi:  10.1159/000335479
    [15] Aktas B, Müller V, Tewes M, et al. Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients[J]. Gynecol Oncol, 2011, 122:356-360. doi:  10.1016/j.ygyno.2011.04.039
    [16] Shimada R, Iinuma H, Akahane T, et al. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients[J]. Oncol Rep, 2012, 27:947-953. doi:  10.3892/or.2012.1649
    [17] Swennenhuis JF, Tibbe AG, Levink R, et al. Characterization of circulating tumor cells by fluorescence in situ hybridization[J]. Cytometry A, 2009, 75:520-527. https://core.ac.uk/display/277393897
    [18] Hayashi N, Nakamura S, Yagata H, et al. Chromosome 17 polysomy in circulating tumor cells in patients with metastatic breast cancer:a case series[J]. Int J Clin Oncol, 2011, 16:596-600. doi:  10.1007/s10147-010-0173-3
    [19] Theodoropoulos PA, Polioudaki H, Agelaki S, et al. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer[J]. Cancer Lett, 2010, 288:99-106. doi:  10.1016/j.canlet.2009.06.027
    [20] Wang N, Shi L, Li H, et al. Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry:a valuable tool for diagnosis and prognosis evaluation[J]. Tumour Biol, 2012, 33:561-569. doi:  10.1007/s13277-011-0303-1
    [21] Raimondi C, Gradilone A, Naso G, et al. Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients[J]. Breast Cancer Res Treat, 2011, 130:449-455. doi:  10.1007/s10549-011-1373-x
    [22] Kasimir-Bauer S, Hoffmann O, Wallwiener D, et al. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells[J]. Breast Cancer Res, 2012, 14:R15. doi:  10.1186/bcr3099
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (179) PDF downloads(29) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return